Skip to main content
. 2020 Feb 3;11(3):681–699. doi: 10.1007/s13300-020-00759-4

Table 2.

Relative proportions of post-index study outcomes, visits, and costs by hypoglycemia risk ventile

Post-index variablea Highest risk stratum (20th ventile) 19th ventile 11–18th ventiles Lowest risk stratum (1–10th ventiles) Overall
Nb %c N % N % N % N
Number of patients 22,672 5.0 22,672 5.0 181,376 40.0 226,719 50.0 453,439
Study outcomes
  Hypoglycemic event 3348 25.9 1797 13.9 5745 44.5 2014 15.6 12,904
  Antidiabetic persistence 2532 3.8 2590 3.9 23,250 35.1 37,790 57.1 66,162
  HbA1c target attainment 8082 6.3 7573 5.9 56,345 43.7 56,982 44.2 128,982
  HbA1c change from baseline 1175 7.1 1177 7.2 7498 45.6 6602 40.1 16,452
  T2D-related inpatient admission 2965 9.8 2501 8.3 14,328 47.3 10,469 34.6 30,263
  T2D-related total medical cost $4114 8.7 $3509 7.4 $2691 45.6 $1801 38.2 $2358
Visits: all-cause
  Inpatient admissions 5608 10.2 4590 8.4 26,082 47.5 18,644 33.9 54,924
  ER visits 7243 7.4 6451 6.6 43,955 44.9 40,313 41.2 97,962
  Outpatient visits 22,420 5.1 22,376 5.1 177,857 40.3 218,783 49.6 441,436
Visits: hypoglycemia-related
  Inpatient admissions 501 26.7 254 13.5 886 47.2 236 12.6 1877
  ER visits 570 24.7 323 14.0 1144 49.6 271 11.7 2308
  Outpatient visits 2164 27.4 1192 15.1 3381 42.9 1153 14.6 7890
Costs
  Healthcare $36,567 10.7 $30,090 8.8 $19,406 45.4 $12,038 35.2 $17,114
  Medical $28,652 11.3 $23,081 9.1 $14,173 44.8 $8825 34.8 $12,669
  Pharmacy $7915 8.9 $7009 7.9 $5233 47.1 $3213 36.1 $4446
  Hypoglycemia-related medical $395 30.1 $167 12.7 $75 45.6 $15 11.6 $66

aAll variables were collected in the 1 year following the index date

bRepresents the count of patients with the relevant study outcome event or visit within ventiles. Patients with multiple visits were only counted once. For cost variables, represents the average costs per patient per year ($/PPY) within ventiles

cRepresents the percentage of patients with the relevant study outcome event or visit within ventiles out of the total number of relevant study outcome events or visits. For costs, represents the percentage of costs within ventiles out total costs